We next analyzed the heterogeneous expression patterns of B2M in gliomas regarding the molecular subtypes, including classical (CL), mesenchymal (ME), pro-neural (PN), and neural (NE), with CL and ME being the more aggressive subtypes32,33. Here, B2M is linked to central nervous system cancer.